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Introduction
Glaucoma is nowadays described as an optic 
neuropathy rather than a disease of elevated blood 
pressure of the eye. It is considered the leading 
cause of irreversible blindness worldwide and it is 
estimated that by the year 2040, more than 10 mil-
lion will be affected. There are 2 types of glauco-
ma: open-angle and angle-closure. Glaucoma usu-
ally results from congenital or acquired lesions of 
the anterior segment of the eye that mechanically 
obstructs aqueous outflow. Primary glaucoma can 
occur without evidence of preexisting ocular or 
systemic diseases while secondary glaucoma can 
result from inflammatory processes that affect the 
eye. Neovascular Glaucoma (NVG) is a type of sec-
ondary glaucoma, where the angle of the eye (be-
tween iris and cornea) is closed by newly formed 
blood vessels, hence the name neovascular. The 
neovascularization of the iris is known as rubeosis 
iridis. It typically develops in eyes with severe reti-
nal blockage or diabetic eye disease.
Diabetic retinopathy
Approximately one third of the patients with ru-
beosis iridis suffer from diabetic retinopathy [1]. The 
likelihood of NVG developing in diabetic patients is 
correlated with glucose control. In such cases, the 
retina becomes ischemic, meaning it does not have 
adequate oxygen supply. At that point retina begins 
to release chemicals to counteract the lack of oxygen, 
including vascular endothelial growth factor (VEGF). 
VEGF promotes new vessel formation, a fact that 
theoretically could enhance the oxygen supply to the 
affected ischemic zone of the retina, but in contrast 
these new vessels are leaky and abnormal. Patients 
having a Central Retinal Vein Occlusion (CRVO) are 
at greater risk of developing NVG. Neovasculariza-
tion sometimes can cause severe bleeding, filling the 
vitreous cavity with blood [2].
Symptoms
Symptoms can include pain, redness and de-
creased vision, however in the early stages of the 
disease it is possible to appear asymptomatic.
Diagnosis
In the prerubeosis stage the anterior segment 
is unremarked with normal Intraocular Pressure. 
Fluorescein Angiography (FA) is recognized as an 
important diagnostic tool. It requires venipunc-
ture and it is related to contrast injections.
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First, dilation of the pupil must occur (drops 
are used), secondly a yellowish colored dye (fluo-
rescein) is injected in a vein, usually of the arm. 
It takes about 10-15 seconds for the dye to travel 
throughout the body. When the dye finally reaches 
the blood vessels of the retina, it causes them to 
«fluoresce». As fluorescein passes through the ret-
ina, a special camera is used to take pictures. These 
pictures are then used to observe the nature and 
the exact locus of the problem. Side effects of FA 
include blurry vision and light sensitivity. 
Optical coherent tomography angiography 
(OCTA) is a non-invasive imaging technique de-
veloped for the observation of the blood vessels 
of the retina. It accesses the retinal structures in 
a microscopic level. The process is fast and reli-
able. It permits the study of choroidal and retinal 
circulation via motion contrast imaging [3]. Slit 
spectrum amplitude decorrelation angiography 
combined with OCTA helps to the further under-
standing of retinal and choroidal vascular diseas-
es. It allows the evaluation of retinal microvascu-
lature and identification of subsequent disorders 
such as microaneurysms, arterial wall staining 
and intraretinal vascular abnormalities [4].
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Treatment
Treatment of NVG includes two parts. Treating 
the ischemic retina and lowering the IOP through 
medications, laser, surgery or combination of these 
types of treatment. Retinal laser is used to de-
crease the production of VEGF. Another approach 
with similar effect is administration of anti-VEGF 
medication. Both treating methods cause the ab-
normal vessels to regress or disappear.
Surgical approach
If the IOP is not adequately controlled, surgery 
is often the next step. Tube shunt surgery and tra-
beculectomy are the most common surgical proce-
dures. If vision is very poor, a less invasive type of 
laser that destroys ciliary body is used [5].
Prevention
Should be focused on preventing the most 
common underlying cause of NVG, including reti-
nal vein blockage and diabetic retinopathy. Con-
trolling blood pressure and diabetes is imperative, 
and especially for diabetes, for individuals above 
the age of 65 years, a comprehensive eye examina-
tion every one or two years is recommended [6].
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Conclusion
Early diagnosis of the NVG with identification 
of the underlying cause followed by immediate 
and aggressive treatment is the key to a better 
outcome. In managing neovascular glaucoma it is 
essential to maintain a high index of predisposing 
posterior segment conditions.
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